Open AccessAbsence of Nasal Mucosal Atrophy With Fluticasone Aqueous Nasal Spray
Author(s) -
Fuad M. Baroody,
C.-C. Cheng,
Birgitta Moylan,
Marcy deTineo,
Lauran Haney,
Kenneth D. Reed,
Cindy K. Cook,
Ronald Westlund,
Elizabeth Sengupta,
Jacquelynne P. Corey,
Alkis Togias,
Robert M. Naclerio
Publication year - 2001
Publication title -
archives of otolaryngology - head and neck surgery
Language(s) - English
Resource type - Journals
eISSN - 1538-361X
pISSN - 0886-4470
DOI - 10.1001/archotol.127.2.193
Subject(s) - fluticasone propionate , fluticasone , terfenadine , nasal spray , medicine , atrophy , mucous membrane of nose , nasal administration , nasal polyps , pathology , gastroenterology , anesthesia , corticosteroid , pharmacology
To evaluate whether 1 year of continuous treatment with intranasal fluticasone propionate would lead to atrophy in the nasal mucosa compared with an active control, oral terfenadine.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom